Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Tu, Honglei ^a   Lei, Bo ^b   Meng, Shan ^b   Liu, Hailing ^b   Wei, Yongchang ^a   He, Aili ^b   Zhang, Wanggang ^b   Zhou, Fuling ^a,b  

^a WUHAN UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; COMPOUND KUSHEN INJECTION; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 4; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BRAIN DYSFUNCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CARDIOTOXICITY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG SAFETY; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; INDUCTION CHEMOTHERAPY; KIDNEY FAILURE; LEUKEMIA REMISSION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PNEUMONIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; TREATMENT RESPONSE;

EID: 84990942857     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/3121402     Document Type: Article

References (36)

1. D. Pulte, A. Gondos, and H. Brenner, "Expected long-term survival of patients diagnosed with acutemyeloblastic leukemia during 2006-2010, " Annals of Oncology, vol. 21, no. 2, pp. 335-341, 2010.
2. N. Howlader, A. M. Noone, M. Krapcho et al., SEER Cancer Statistics Review, 1975-2009, National Cancer Institute, Bethesda, Md, USA, 2012.
3. J. M. Vagace and G. Gervasini, "Chemotherapy toxicity in patients with acute leukemia, " in Acute Leukemia-The Scientist's Perspective and Challenge, M. Antica, Ed., chapter 17, InTech, Rijeka, Croatia, 2011.
4. "Challenges in research and development of traditional chinese medicines, " Chinese Herbal Medicines, no. 1, pp. 1-28, 2009.
5. Q. Ji, Y. Luo, W. Wang, X. Liu, Q. Li, and S. Su, "Research advances in traditional Chinese medicine syndromes in cancer patients, " Journal of IntegrativeMedicine, vol. 14, no. 1, pp. 12-21, 2016.
6. C.-L. Qian, F. Yan, Y.-Z. Song, D. Li, K.-Z. Dong, andY.-M. Zhu, "Is the traditional Chinese medicine helpful for patients with hematologic malignant diseases A meta-analysis of randomized controlled trials, " World Journal ofMeta-Analysis, vol. 3, no. 3, pp. 163-180, 2015.
7. Z. Liu, S. Chen, J. Cai et al., "Traditional Chinese Medicine syndrome-related herbal prescriptions in treatment of malignant tumors, " Journal of Traditional Chinese Medicine, vol. 33, no. 1, pp. 19-26, 2013.
8. J. Tian, W.-H. Wang, H.-M. Cao, and Z.-M. Wang, "Determination of matrine, sophoridine and oxymatrine in compound Kushen injection by HPLC, " China Journal of Chinese Materia Medica, vol. 32, no. 3, pp. 222-224, 2007.
9. Q. I. Liang, J. Zhang, and Z. Zhang, "Determination of four alkaloids in compound Kushen Injection by high performance liquid chromatography with ionic liquid as mobile phase additive, " Chinese Journal of Chromatography, vol. 31, no. 3, pp. 249-253, 2013.
10. Z. Z. Qian, Y. Dan, Y. Z. Liu, and Y. Peng, "Pharmacopoeia of the People's Republic of China (2010 edition): A milestone in development of China's healthcare, " Chinese Herbal Medicines, vol. 2, no. 2, pp. 157-160, 2010.
11. M. Sun, H. Cao, L. Sun et al., "Antitumor activities of kushen: literature review, " Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 373219, 11 pages, 2012.
12. X. Ma, R.-S. Li, J. Wang et al., "The therapeutic efficacy and safety of compound kushen injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An update systematic review and meta-analysis, " Frontiers in Pharmacology, vol. 7, article 70, 2016.
13. W. Xu, H. Lin, Y. Zhang et al., "Compound Kushen Injection suppresses human breast cancer stem-like cells by downregulating the canonical Wnt/-catenin pathway, " Journal of Experimental and Clinical Cancer Research, vol. 30, no. 1, article 103, 2011.
14. L. Yin, W. L. Zheng, Q. Z. Sun, Y. F. Peng, and M. A. Wen-Li, "Meta-analysis of efficiency in treatment of gastric cancer by compound Kushen injection combined with chemotherapy, " Chinese Journal of Experimental Traditional Medical Formulae, vol. 19, no. 14, pp. 325-330, 2013.
15. Z. Y. Wang, G. S. Li, and H. X. Huang, "Clinical observation on treatment of 75 mid-late stage cancer patients with Yanshu injection, " Chinese Journal of Integrated Traditional & Western Medicine, vol. 26, no. 8, pp. 681-684, 2006.
16. J. Chen, Q. Mei, Y.-C. Xu, J. Du, Y. Wei, and Z.-M. Xu, "Effects of Matrine injection on T-lymphocyte subsets of patients with malignant tumor after gamma knife radiosurgery, " Journal of Chinese Integrative Medicine, vol. 4, no. 1, pp. 78-79, 2006.
17. B. Yanju, L. Yang, B. Hua et al., "A systematic review and metaanalysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain, " Supportive Care in Cancer, vol. 22, no. 3, pp. 825-836, 2014.
18. L. Guerretta, "Common Terminology Criteria for Adverse Events v3. 0 (CTCAE), " 2003.
19. R. Guangxin, L. I. Hegen, L. Zhao, L. Liu, L. Shen, and L. Zhou, "Effect of method of strengthening genuine qi on tumor microenvironment of advanced non-small cell lung cancer, " Journal of Liaoning University of Traditional Chinese Medicine, no. 6, pp. 157-159, 2013.
20. M. Xu, G. Zhang, L. Pan et al., "Effects of Chinese herbs of strengthening and invigorating genuine Qi on multidrug resistant lung cancer cells through regulation of mitochondria related molecules, " Chinese Journal of Clinical Oncology, vol. 37, no. 13, pp. 725-728, 2011.
21. M. R. Corces-Zimmerman and R. Majeti, "Pre-leukemic evolution of hematopoietic stem cells: The importance of early mutations in leukemogenesis, " Leukemia, vol. 28, no. 12, pp. 2276-2282, 2014.
22. S. Kanji, V. J. Pompili, and H. Das, "Plasticity and maintenance of hematopoietic stemcells during development, " Recent Patents on Biotechnology, vol. 5, no. 1, pp. 40-53, 2011.
23. A. Nazha and F. Ravandi, "Acute myeloid leukemia in the elderly: do we know who should be treated and how" Leukemia & Lymphoma, vol. 55, no. 5, pp. 979-987, 2014.
24. C. Rébé and F. Ghiringhelli, "Cytotoxic effects of chemotherapy on cancer and immune cells: how can it be modulated to generate novel therapeutic strategies" Future Oncology, vol. 11, no. 19, pp. 2645-2654, 2015.
25. R. G. van derMost, A. Currie, B. W. S. Robinson, and R. A. Lake, "Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunity, " Cancer Research, vol. 66, no. 2, pp. 601-604, 2006.
26. P. Olioso, R. Giancola, M. Di Riti, A. Contento, P. Accorsi, and A. Iacone, "Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: A pilot clinical trial, " Hematological Oncology, vol. 27, no. 3, pp. 130-139, 2009.
27. S. Alanko, T.-T. Pelliniemi, and T. T. Salmi, "Recovery of blood B-lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia, " Cancer, vol. 69, no. 6, pp. 1481-1486, 1992.
28. X. Liu, H. Li, L. Wu et al., "Simultaneous quantification of chrysophanol and physcion in rat plasma by ultra fast liquid chromatography-tandemmass spectrometry and application of the technique to comparative pharmacokinetic studies of Radix et Rhei Rhizoma extract alone and Dahuang Fuzi Decoction, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 980, pp. 88-93, 2015.
29. Y. Jin, C. Qu, Y. Tang et al., "Herb pairs containing Angelicae Sinensis Radix (Danggui): A review of bio-active constituents and compatibility effects, " Journal of Ethnopharmacology, vol. 181, pp. 158-171, 2016.
30. A. K. Drew, A. Bensoussan, I. M. Whyte, A. H. Dawson, X. Zhu, and S. P. S. Myers, "Chinese herbal medicine toxicology database: monograph on Radix Sophorae Flavescentis, 'Ku Shen', " Journal of Toxicology: Clinical Toxicology, vol. 40, no. 2, pp. 173-176, 2002.
31. G. P. Zhang, S. H. Xie, X. G. Zhu et al., "Experimental study on effects of radix glycyrrhizae on toxicity and efficacy of radix aconiti carmichaeli in compatibility, " Chinese Journal of Information on Traditional Chinese Medicine, no. 6, pp. 31-34, 2012.
32. J. Y. Lee, J.-H. Lee, J. H. Park et al., "Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not, " International Immunopharmacology, vol. 9, no. 5, pp. 632-638, 2009.
33. Y.-W. Shin, E.-A. Bae, B. Lee et al., "In vitro and in vivo antiallergic effects of Glycyrrhiza glabra and its components, " Planta Medica, vol. 73, no. 3, pp. 257-261, 2007.
34. S. C. Kim, S. H. Byun, C. H. Yang, C. Y. Kim, J. W. Kim, and S. G. Kim, "Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmiuminduced toxicity (effects on bad translocation and cytochrome c-mediated PARP cleavage), " Toxicology, vol. 197, no. 3, pp. 239-251, 2004.
35. L. Shi, X. Tang, X. Dang et al., "Investigating herb-herb interactions: The potential attenuated toxicitymechanism of thecombined use of Glycyrrhizae radix et rhizoma (Gancao) and Sophorae flavescentis radix (Kushen), " Journal of Ethnopharmacology, vol. 165, pp. 243-250, 2015.
36. X. Wang, X. Huang, N. Wang et al., "Toxicity of the water extraction of radix sophorae flavescentis formulated with radix glycyrrhizae on mice, " Chinese Archives of Traditional Chinese Medicine, vol. 33, no. 7, pp. 1653-1655, 2015.